Keyphrases
Hypoglycemia
100%
Mixed Connective Tissue Disease
100%
Insulin Receptor Antibody
100%
Severe Hypoglycemia
66%
Insulin Receptor
50%
Immunosuppression
33%
Rituximab
33%
Severe Insulin Resistance
33%
Hyperglycemia
16%
Insulin Resistance
16%
Physiologic
16%
Growth Factors
16%
Autoantibodies
16%
Insulin-like
16%
Clinical Setting
16%
Oncologic
16%
Hemorrhagic Stroke
16%
Antibody-mediated
16%
Older Women
16%
Adrenal Function
16%
Myopathy
16%
Antibody Titer
16%
Obesity-related Hypertension
16%
Rheumatologic
16%
Antibody Test
16%
Asymptomatic Hypoglycemia
16%
Anti-insulin Antibody
16%
Systemic Autoimmune Diseases
16%
Plasma Acylcarnitine
16%
Acylcarnitine Profile
16%
Type B Insulin Resistance Syndrome
16%
Progressive Myopathies
16%
Immunology and Microbiology
Autoantibodies
100%
Insulin Receptor
100%
Mixed Connective Tissue Disease
100%
Insulin Resistance
80%
Insulin Receptor Antibody
60%
Glucocorticoid
60%
Immunosuppression
40%
Rituximab
40%
Blood Plasma
20%
Antibody Titer
20%
Insulin Antibody
20%
Systemic Autoimmune Disease
20%
Somatomedin B
20%
Adrenal Function
20%
Medicine and Dentistry
Autoantibodies
100%
Hypoglycemia
100%
Insulin Receptor
100%
Mixed Connective Tissue Disease
100%
Insulin Resistance
36%
Glucocorticoid
27%
Insulin Receptor Antibody
27%
Immunosuppressive Treatment
18%
Rituximab
18%
Myopathy
18%
Diagnosis
9%
Hyperglycemia
9%
Cerebral Hemorrhage
9%
Adrenal Function
9%
Acylcarnitine
9%
Somatomedin B
9%
Insulin Antibody
9%
Systemic Autoimmune Disease
9%
Veterinary Science and Veterinary Medicine
Mixed Connective Tissue Disease
100%
Autoantibody
100%
Glucocorticoid
75%
Myopathy
50%
Insulin-Like Growth Factor 2
25%
Blood Plasma
25%
Biochemistry, Genetics and Molecular Biology
Insulin Receptor
100%
Autoantibodies
100%
Insulin Resistance
50%
Glucocorticoid
37%
Rituximab
25%
Hyperglycemia
12%
Adrenal Function
12%
Titer
12%
Insulin-Like Growth Factor 2
12%
Blood Plasma
12%